Singapore - English - HSA (Health Sciences Authority)

sanofi-aventis singapore pte. ltd. - alfuzosin hcl - tablet - 10 mg - alfuzosin hcl 10 mg

Singapore - English - HSA (Health Sciences Authority)

sanofi-aventis singapore pte. ltd. - alfuzosin hcl - tablet, extended release - 5 mg - alfuzosin hcl 5 mg

Australia - English - Department of Health (Therapeutic Goods Administration)

merck serono australia pty ltd - sapropterin dihydrochloride -

New Zealand - English - Medsafe (Medicines Safety Authority)

clinect nz pty limited - iloprost 0.1 mg/ml equivalent to iloprost trometamol 0.134 mg/ml;   - concentrate for infusion - 0.05 mg/0.5ml - active: iloprost 0.1 mg/ml equivalent to iloprost trometamol 0.134 mg/ml   excipient: ethanol as 96% v/v hydrochloric acid as 1m hcl nitrogen sodium chloride trometamol water for injection - treatment of patients with severe peripheral arterial occlusive disease (poad), particularly those at risk of amputation and in whom surgery or angioplasty is not possible. treatment of advanced thromboangitis obliterans (buerger's disease) with critical limb ischaemia in cases where revascularisation is not indicated. treatment of patients with severe disabling raynaud's phenomenon unresponsive to other therapies. treatment of moderate or severe primary and secondary pulmonary hypertension such as new york heart association functional classes iii and iv.

New Zealand - English - Medsafe (Medicines Safety Authority)

bayer new zealand limited - iloprost trometamol 134 µg/ml equivalent to 100 µg iloprost/ml;  ;   - solution for infusion - 50 mcg/0.5ml - active: iloprost trometamol 134 µg/ml equivalent to 100 µg iloprost/ml     excipient: ethanol hydrochloric acid sodium chloride trometamol water for injection - treatment of patients with severe peripheral arterial occlusive disease (paod) particularly those at risk of amputation and in whom surgery or angioplasty is not possible.

New Zealand - English - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - sapropterin dihydrochloride 100mg equivalent to 77 mg sapropterin - soluble tablet - 100 mg - active: sapropterin dihydrochloride 100mg equivalent to 77 mg sapropterin excipient: ascorbic acid calcium hydrogen phosphate crospovidone mannitol riboflavin sodium stearyl fumarate - kuvan is indicated for the treatment of hyperphenylalaninemia (hpa) in sapropterin-responsive adult and paediatric patients with phenylketonuria (pku) or tetrahydrobiopterin (bh4) deficiency.

Israel - English - Ministry of Health

bayer israel ltd - iloprost - concentrate for solution for infusion - iloprost 0.1 mg/ml - iloprost - iloprost - peripheral arterial occlusive disease (stage 3 and 4 of fontaine's classification) in advanced arteriosclerosis, in whom surgery or angioplasty therapy is not possible.thromboangitis obliterans (buerger's disease) with critical limb ischemia in cases where revascularisation is not indicated and severe disabling raynaud's phenomenon .

Israel - English - Ministry of Health

sanofi israel ltd - alfuzosin hydrochloride - tablets prolonged release - alfuzosin hydrochloride 10 mg - alfuzosin - alfuzosin - treatment of certain functional symptoms of benign prostatic hypertrophy particularly if surgery has to be delayed for some reason. adjuvant treatment to a catheter in acute urinary retention related to benign prostatic hypertrophy.

New Zealand - English - Medsafe (Medicines Safety Authority)

te arai biofarma limited - sapropterin dihydrochloride 100mg equivalent to 76.8 mg sapropterin - soluble tablet - 100 mg - active: sapropterin dihydrochloride 100mg equivalent to 76.8 mg sapropterin excipient: ascorbic acid colloidal silicon dioxide copovidone crospovidone mannitol riboflavin sodium stearyl fumarate - indicated for the treatment of hyperphenylalaninemia (hpa) in sapropterin-responsive adult and paediatric patients with phenylketonuria (pku) or tetrahydrobiopterin (bh4) deficiency.

Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

sanofi-aventis (malaysia) sdn. bhd. - alfuzosin -